The RNA Analysis And Transcriptomics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global RNA Analysis And Transcriptomics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global RNA Analysis And Transcriptomics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
RNA Analysis And Transcriptomics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Microarrays
Polymerase Chain Reaction
Sequencing Technologies
RNAI Gene Silencing
Market segment by Application, can be divided into
Academic Research Institutes
Pharmaceutical Companies
Hospitals and Diagnostic Centers
Market segment by players, this report covers
Affymetrix Inc.(Thermo Fisher Scientific)
Agilent Technologies, Inc.
Bio-Rad Laboratories
GE Healthcare Systems(GE)
Illumina, Inc.
Qiagen N.V.
F. Hoffmann-La Roche Ltd.
Sigma-Aldrich(Merck KGaA)
Fluidigm Corporation
Danaher Corporation
Acobiom
Lexogen GmbH
Promega Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of RNA Analysis And Transcriptomics
1.2 Classification of RNA Analysis And Transcriptomics by Type
1.2.1 Overview: Global RNA Analysis And Transcriptomics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global RNA Analysis And Transcriptomics Revenue Market Share by Type in 2020
1.2.3 Microarrays
1.2.4 Polymerase Chain Reaction
1.2.5 Sequencing Technologies
1.2.6 RNAI Gene Silencing
1.3 Global RNA Analysis And Transcriptomics Market by End Users
1.3.1 Overview: Global RNA Analysis And Transcriptomics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Academic Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Hospitals and Diagnostic Centers
1.4 Global RNA Analysis And Transcriptomics Market Size & Forecast
1.5 Global RNA Analysis And Transcriptomics Market Size and Forecast by Region
1.5.1 Global RNA Analysis And Transcriptomics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global RNA Analysis And Transcriptomics Market Size by Region, (2016-2021)
1.5.3 North America RNA Analysis And Transcriptomics Market Size and Prospect (2016-2026)
1.5.4 Europe RNA Analysis And Transcriptomics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific RNA Analysis And Transcriptomics Market Size and Prospect (2016-2026)
1.5.6 South America RNA Analysis And Transcriptomics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa RNA Analysis And Transcriptomics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 RNA Analysis And Transcriptomics Market Drivers
1.6.2 RNA Analysis And Transcriptomics Market Restraints
1.6.3 RNA Analysis And Transcriptomics Trends Analysis
2 Company Profiles
2.1 Affymetrix Inc.(Thermo Fisher Scientific)
2.1.1 Affymetrix Inc.(Thermo Fisher Scientific) Details
2.1.2 Affymetrix Inc.(Thermo Fisher Scientific) Major Business
2.1.3 Affymetrix Inc.(Thermo Fisher Scientific) RNA Analysis And Transcriptomics Product and Solutions
2.1.4 Affymetrix Inc.(Thermo Fisher Scientific) RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Affymetrix Inc.(Thermo Fisher Scientific) Recent Developments and Future Plans
2.2 Agilent Technologies, Inc.
2.2.1 Agilent Technologies, Inc. Details
2.2.2 Agilent Technologies, Inc. Major Business
2.2.3 Agilent Technologies, Inc. RNA Analysis And Transcriptomics Product and Solutions
2.2.4 Agilent Technologies, Inc. RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories RNA Analysis And Transcriptomics Product and Solutions
2.3.4 Bio-Rad Laboratories RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 GE Healthcare Systems(GE)
2.4.1 GE Healthcare Systems(GE) Details
2.4.2 GE Healthcare Systems(GE) Major Business
2.4.3 GE Healthcare Systems(GE) RNA Analysis And Transcriptomics Product and Solutions
2.4.4 GE Healthcare Systems(GE) RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GE Healthcare Systems(GE) Recent Developments and Future Plans
2.5 Illumina, Inc.
2.5.1 Illumina, Inc. Details
2.5.2 Illumina, Inc. Major Business
2.5.3 Illumina, Inc. RNA Analysis And Transcriptomics Product and Solutions
2.5.4 Illumina, Inc. RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Illumina, Inc. Recent Developments and Future Plans
2.6 Qiagen N.V.
2.6.1 Qiagen N.V. Details
2.6.2 Qiagen N.V. Major Business
2.6.3 Qiagen N.V. RNA Analysis And Transcriptomics Product and Solutions
2.6.4 Qiagen N.V. RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Qiagen N.V. Recent Developments and Future Plans
2.7 F. Hoffmann-La Roche Ltd.
2.7.1 F. Hoffmann-La Roche Ltd. Details
2.7.2 F. Hoffmann-La Roche Ltd. Major Business
2.7.3 F. Hoffmann-La Roche Ltd. RNA Analysis And Transcriptomics Product and Solutions
2.7.4 F. Hoffmann-La Roche Ltd. RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.8 Sigma-Aldrich(Merck KGaA)
2.8.1 Sigma-Aldrich(Merck KGaA) Details
2.8.2 Sigma-Aldrich(Merck KGaA) Major Business
2.8.3 Sigma-Aldrich(Merck KGaA) RNA Analysis And Transcriptomics Product and Solutions
2.8.4 Sigma-Aldrich(Merck KGaA) RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sigma-Aldrich(Merck KGaA) Recent Developments and Future Plans
2.9 Fluidigm Corporation
2.9.1 Fluidigm Corporation Details
2.9.2 Fluidigm Corporation Major Business
2.9.3 Fluidigm Corporation RNA Analysis And Transcriptomics Product and Solutions
2.9.4 Fluidigm Corporation RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Fluidigm Corporation Recent Developments and Future Plans
2.10 Danaher Corporation
2.10.1 Danaher Corporation Details
2.10.2 Danaher Corporation Major Business
2.10.3 Danaher Corporation RNA Analysis And Transcriptomics Product and Solutions
2.10.4 Danaher Corporation RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Danaher Corporation Recent Developments and Future Plans
2.11 Acobiom
2.11.1 Acobiom Details
2.11.2 Acobiom Major Business
2.11.3 Acobiom RNA Analysis And Transcriptomics Product and Solutions
2.11.4 Acobiom RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Acobiom Recent Developments and Future Plans
2.12 Lexogen GmbH
2.12.1 Lexogen GmbH Details
2.12.2 Lexogen GmbH Major Business
2.12.3 Lexogen GmbH RNA Analysis And Transcriptomics Product and Solutions
2.12.4 Lexogen GmbH RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Lexogen GmbH Recent Developments and Future Plans
2.13 Promega Corporation
2.13.1 Promega Corporation Details
2.13.2 Promega Corporation Major Business
2.13.3 Promega Corporation RNA Analysis And Transcriptomics Product and Solutions
2.13.4 Promega Corporation RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Promega Corporation Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global RNA Analysis And Transcriptomics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 RNA Analysis And Transcriptomics Players Market Share
3.2.2 Top 10 RNA Analysis And Transcriptomics Players Market Share
3.2.3 Market Competition Trend
3.3 RNA Analysis And Transcriptomics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global RNA Analysis And Transcriptomics Revenue and Market Share by Type (2016-2021)
4.2 Global RNA Analysis And Transcriptomics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global RNA Analysis And Transcriptomics Revenue Market Share by Application (2016-2021)
5.2 RNA Analysis And Transcriptomics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America RNA Analysis And Transcriptomics Revenue by Type (2016-2026)
6.2 North America RNA Analysis And Transcriptomics Revenue by Application (2016-2026)
6.3 North America RNA Analysis And Transcriptomics Market Size by Country
6.3.1 North America RNA Analysis And Transcriptomics Revenue by Country (2016-2026)
6.3.2 United States RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
6.3.3 Canada RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
6.3.4 Mexico RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe RNA Analysis And Transcriptomics Revenue by Type (2016-2026)
7.2 Europe RNA Analysis And Transcriptomics Revenue by Application (2016-2026)
7.3 Europe RNA Analysis And Transcriptomics Market Size by Country
7.3.1 Europe RNA Analysis And Transcriptomics Revenue by Country (2016-2026)
7.3.2 Germany RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
7.3.3 France RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
7.3.5 Russia RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
7.3.6 Italy RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific RNA Analysis And Transcriptomics Revenue by Type (2016-2026)
8.2 Asia-Pacific RNA Analysis And Transcriptomics Revenue by Application (2016-2026)
8.3 Asia-Pacific RNA Analysis And Transcriptomics Market Size by Region
8.3.1 Asia-Pacific RNA Analysis And Transcriptomics Revenue by Region (2016-2026)
8.3.2 China RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
8.3.3 Japan RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
8.3.4 South Korea RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
8.3.5 India RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
8.3.7 Australia RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America RNA Analysis And Transcriptomics Revenue by Type (2016-2026)
9.2 South America RNA Analysis And Transcriptomics Revenue by Application (2016-2026)
9.3 South America RNA Analysis And Transcriptomics Market Size by Country
9.3.1 South America RNA Analysis And Transcriptomics Revenue by Country (2016-2026)
9.3.2 Brazil RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
9.3.3 Argentina RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa RNA Analysis And Transcriptomics Revenue by Type (2016-2026)
10.2 Middle East & Africa RNA Analysis And Transcriptomics Revenue by Application (2016-2026)
10.3 Middle East & Africa RNA Analysis And Transcriptomics Market Size by Country
10.3.1 Middle East & Africa RNA Analysis And Transcriptomics Revenue by Country (2016-2026)
10.3.2 Turkey RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
10.3.4 UAE RNA Analysis And Transcriptomics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global RNA Analysis And Transcriptomics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global RNA Analysis And Transcriptomics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market RNA Analysis And Transcriptomics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global RNA Analysis And Transcriptomics Revenue (USD Million) by Region (2016-2021)
Table 5. Global RNA Analysis And Transcriptomics Revenue Market Share by Region (2021-2026)
Table 6. Affymetrix Inc.(Thermo Fisher Scientific) Corporate Information, Head Office, and Major Competitors
Table 7. Affymetrix Inc.(Thermo Fisher Scientific) Major Business
Table 8. Affymetrix Inc.(Thermo Fisher Scientific) RNA Analysis And Transcriptomics Product and Solutions
Table 9. Affymetrix Inc.(Thermo Fisher Scientific) RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Agilent Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Technologies, Inc. Major Business
Table 12. Agilent Technologies, Inc. RNA Analysis And Transcriptomics Product and Solutions
Table 13. Agilent Technologies, Inc. RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Laboratories Major Business
Table 16. Bio-Rad Laboratories RNA Analysis And Transcriptomics Product and Solutions
Table 17. Bio-Rad Laboratories RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GE Healthcare Systems(GE) Corporate Information, Head Office, and Major Competitors
Table 19. GE Healthcare Systems(GE) Major Business
Table 20. GE Healthcare Systems(GE) RNA Analysis And Transcriptomics Product and Solutions
Table 21. GE Healthcare Systems(GE) RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Illumina, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Illumina, Inc. Major Business
Table 24. Illumina, Inc. RNA Analysis And Transcriptomics Product and Solutions
Table 25. Illumina, Inc. RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Qiagen N.V. Corporate Information, Head Office, and Major Competitors
Table 27. Qiagen N.V. Major Business
Table 28. Qiagen N.V. RNA Analysis And Transcriptomics Product and Solutions
Table 29. Qiagen N.V. RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. F. Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors
Table 31. F. Hoffmann-La Roche Ltd. Major Business
Table 32. F. Hoffmann-La Roche Ltd. RNA Analysis And Transcriptomics Product and Solutions
Table 33. F. Hoffmann-La Roche Ltd. RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sigma-Aldrich(Merck KGaA) Corporate Information, Head Office, and Major Competitors
Table 35. Sigma-Aldrich(Merck KGaA) Major Business
Table 36. Sigma-Aldrich(Merck KGaA) RNA Analysis And Transcriptomics Product and Solutions
Table 37. Sigma-Aldrich(Merck KGaA) RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Fluidigm Corporation Corporate Information, Head Office, and Major Competitors
Table 39. Fluidigm Corporation Major Business
Table 40. Fluidigm Corporation RNA Analysis And Transcriptomics Product and Solutions
Table 41. Fluidigm Corporation RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Danaher Corporation Corporate Information, Head Office, and Major Competitors
Table 43. Danaher Corporation Major Business
Table 44. Danaher Corporation RNA Analysis And Transcriptomics Product and Solutions
Table 45. Danaher Corporation RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Acobiom Corporate Information, Head Office, and Major Competitors
Table 47. Acobiom Major Business
Table 48. Acobiom RNA Analysis And Transcriptomics Product and Solutions
Table 49. Acobiom RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Lexogen GmbH Corporate Information, Head Office, and Major Competitors
Table 51. Lexogen GmbH Major Business
Table 52. Lexogen GmbH RNA Analysis And Transcriptomics Product and Solutions
Table 53. Lexogen GmbH RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Promega Corporation Corporate Information, Head Office, and Major Competitors
Table 55. Promega Corporation Major Business
Table 56. Promega Corporation RNA Analysis And Transcriptomics Product and Solutions
Table 57. Promega Corporation RNA Analysis And Transcriptomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global RNA Analysis And Transcriptomics Revenue (USD Million) by Players (2019-2021)
Table 59. Global RNA Analysis And Transcriptomics Revenue Share by Players (2019-2021)
Table 60. Breakdown of RNA Analysis And Transcriptomics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. RNA Analysis And Transcriptomics Players Head Office, Products and Services Provided
Table 62. RNA Analysis And Transcriptomics Mergers & Acquisitions in the Past Five Years
Table 63. RNA Analysis And Transcriptomics New Entrants and Expansion Plans
Table 64. Global RNA Analysis And Transcriptomics Revenue (USD Million) by Type (2016-2021)
Table 65. Global RNA Analysis And Transcriptomics Revenue Share by Type (2016-2021)
Table 66. Global RNA Analysis And Transcriptomics Revenue Forecast by Type (2021-2026)
Table 67. Global RNA Analysis And Transcriptomics Revenue by Application (2016-2021)
Table 68. Global RNA Analysis And Transcriptomics Revenue Forecast by Application (2021-2026)
Table 69. North America RNA Analysis And Transcriptomics Revenue by Type (2016-2021) & (USD Million)
Table 70. North America RNA Analysis And Transcriptomics Revenue by Type (2021-2026) & (USD Million)
Table 71. North America RNA Analysis And Transcriptomics Revenue by Application (2016-2021) & (USD Million)
Table 72. North America RNA Analysis And Transcriptomics Revenue by Application (2021-2026) & (USD Million)
Table 73. North America RNA Analysis And Transcriptomics Revenue by Country (2016-2021) & (USD Million)
Table 74. North America RNA Analysis And Transcriptomics Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe RNA Analysis And Transcriptomics Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe RNA Analysis And Transcriptomics Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe RNA Analysis And Transcriptomics Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe RNA Analysis And Transcriptomics Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe RNA Analysis And Transcriptomics Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe RNA Analysis And Transcriptomics Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific RNA Analysis And Transcriptomics Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific RNA Analysis And Transcriptomics Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific RNA Analysis And Transcriptomics Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific RNA Analysis And Transcriptomics Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific RNA Analysis And Transcriptomics Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific RNA Analysis And Transcriptomics Revenue by Region (2021-2026) & (USD Million)
Table 87. South America RNA Analysis And Transcriptomics Revenue by Type (2016-2021) & (USD Million)
Table 88. South America RNA Analysis And Transcriptomics Revenue by Type (2021-2026) & (USD Million)
Table 89. South America RNA Analysis And Transcriptomics Revenue by Application (2016-2021) & (USD Million)
Table 90. South America RNA Analysis And Transcriptomics Revenue by Application (2021-2026) & (USD Million)
Table 91. South America RNA Analysis And Transcriptomics Revenue by Country (2016-2021) & (USD Million)
Table 92. South America RNA Analysis And Transcriptomics Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa RNA Analysis And Transcriptomics Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa RNA Analysis And Transcriptomics Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa RNA Analysis And Transcriptomics Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa RNA Analysis And Transcriptomics Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa RNA Analysis And Transcriptomics Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa RNA Analysis And Transcriptomics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. RNA Analysis And Transcriptomics Picture
Figure 2. Global RNA Analysis And Transcriptomics Revenue Market Share by Type in 2020
Figure 3. Microarrays
Figure 4. Polymerase Chain Reaction
Figure 5. Sequencing Technologies
Figure 6. RNAI Gene Silencing
Figure 7. RNA Analysis And Transcriptomics Revenue Market Share by End Users in 2020
Figure 8. Academic Research Institutes Picture
Figure 9. Pharmaceutical Companies Picture
Figure 10. Hospitals and Diagnostic Centers Picture
Figure 11. Global RNA Analysis And Transcriptomics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global RNA Analysis And Transcriptomics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global RNA Analysis And Transcriptomics Revenue Market Share by Region (2016-2026)
Figure 14. Global RNA Analysis And Transcriptomics Revenue Market Share by Region in 2020
Figure 15. North America RNA Analysis And Transcriptomics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe RNA Analysis And Transcriptomics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific RNA Analysis And Transcriptomics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America RNA Analysis And Transcriptomics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. RNA Analysis And Transcriptomics Market Drivers
Figure 20. RNA Analysis And Transcriptomics Market Restraints
Figure 21. RNA Analysis And Transcriptomics Market Trends
Figure 22. Affymetrix Inc.(Thermo Fisher Scientific) Recent Developments and Future Plans
Figure 23. Agilent Technologies, Inc. Recent Developments and Future Plans
Figure 24. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 25. GE Healthcare Systems(GE) Recent Developments and Future Plans
Figure 26. Illumina, Inc. Recent Developments and Future Plans
Figure 27. Qiagen N.V. Recent Developments and Future Plans
Figure 28. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Figure 29. Sigma-Aldrich(Merck KGaA) Recent Developments and Future Plans
Figure 30. Fluidigm Corporation Recent Developments and Future Plans
Figure 31. Danaher Corporation Recent Developments and Future Plans
Figure 32. Acobiom Recent Developments and Future Plans
Figure 33. Lexogen GmbH Recent Developments and Future Plans
Figure 34. Promega Corporation Recent Developments and Future Plans
Figure 36. Global RNA Analysis And Transcriptomics Revenue Share by Players in 2020
Figure 37. RNA Analysis And Transcriptomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players RNA Analysis And Transcriptomics Revenue Market Share in 2020
Figure 39. Global Top 10 Players RNA Analysis And Transcriptomics Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global RNA Analysis And Transcriptomics Revenue Share by Type in 2020
Figure 42. Global RNA Analysis And Transcriptomics Market Share Forecast by Type (2021-2026)
Figure 43. Global RNA Analysis And Transcriptomics Revenue Share by Application in 2020
Figure 44. Global RNA Analysis And Transcriptomics Market Share Forecast by Application (2021-2026)
Figure 45. North America RNA Analysis And Transcriptomics Sales Market Share by Type (2016-2026)
Figure 46. North America RNA Analysis And Transcriptomics Sales Market Share by Application (2016-2026)
Figure 47. North America RNA Analysis And Transcriptomics Revenue Market Share by Country (2016-2026)
Figure 48. United States RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe RNA Analysis And Transcriptomics Sales Market Share by Type (2016-2026)
Figure 52. Europe RNA Analysis And Transcriptomics Sales Market Share by Application (2016-2026)
Figure 53. Europe RNA Analysis And Transcriptomics Revenue Market Share by Country (2016-2026)
Figure 54. Germany RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific RNA Analysis And Transcriptomics Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific RNA Analysis And Transcriptomics Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific RNA Analysis And Transcriptomics Revenue Market Share by Region (2016-2026)
Figure 62. China RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America RNA Analysis And Transcriptomics Sales Market Share by Type (2016-2026)
Figure 69. South America RNA Analysis And Transcriptomics Sales Market Share by Application (2016-2026)
Figure 70. South America RNA Analysis And Transcriptomics Revenue Market Share by Country (2016-2026)
Figure 71. Brazil RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa RNA Analysis And Transcriptomics Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa RNA Analysis And Transcriptomics Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa RNA Analysis And Transcriptomics Revenue Market Share by Country (2016-2026)
Figure 76. Turkey RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE RNA Analysis And Transcriptomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source